London stocks edged higher on Friday, rebounding after two sessions of losses, as Glencore provided a boost amid early talks ...

AbbVie on Thursday denied that it is in talks to buy cancer-drug biotech Revolution Medicines, sending both stocks lower ...

Ventyx Biosciences shares rose 29% after The Wall Street Journal reported that the company is in advanced talks to be ...

Andrew Ross Sorkin talks about the bipartisan effort to put limitations on Congress members buying and selling stocks, ...

AbbVie stock fell after denying Revolution Medicines buyout talks. Company also cut 2025 earnings forecast to $9.90-$9.94 per ...

FTSE 100 rises thanks to a jump for Glencore on talks for a mining mega-deal with Rio Tinto, which is boosting others in the ...

Revolution Medicines (NASDAQ:RVMD) stock closed higher by 5% Thursday and added another 15% after-hours following a Financial Times report that Merck (NYSE:MRK) is in talks to acquire the biotech ...

Investing.com -- Ventyx Biosciences (NASDAQ:VTYX) stock surged 5% and was halted for volatility following reports that Eli Lilly (NYSE:LLY) is in advanced talks to acquire the biotech company for more ...

Investing.com -- British equities opened higher on Friday, snapping a two-day losing streak, as sterling remained under pressure and major UK news included a potential merger between Glencore and Rio ...

India's National Stock Exchange is in discussions with Indian Gas Exchange, or IGX, to develop and launch Indian natural gas ...

Nvidia stock wasn’t boosted by the chip maker’s unveiling of a suite of products designed for robotics and autonomous driving ...

Glencore has confirmed media speculation that the company is back in merger talks with Rio Tinto. Follow updates live on our ...